Aim: The aim of the study was to determine the aqueous solubility of ornidazole using different hydrotropic agents then prepare a solid dispersion of ornidazole by mixed hydrotropic solubilization technique and their characterization. Materials and Methods: Equilibrium solubilities of ornidazole in different aqueous mediums were determined at room temperature. The volumetric flask was shaken on mechanical shaker for 12 h so that equilibrium solubility can be achieved and the solution was allowed to equilibrate undisturbed for 24 h. For the preparation of hydrotropic solid dispersion containing ornidazole and hydrotropic blend, minimum quantity of distilled water at 68°C-70°C contained in a 200 ml beaker was used to dissolve the urea and nicotinamide. Then, ornidazole was added to this beaker (at 35°C-40°C) and a Teflon-coated magnetic bead was dropped in it. Magnetic bead was stirring in a beaker using a magnetic stirrer, maintaining the temperature at 35°C-40°C. The prepared solid dispersions of ornidazole have been characterized by X-ray diffraction (XRD), differential scanning calorimetry (DSC), and infrared (IR) studies. Results and Discussion: The hydrotropic blend urea and nicotinamide (1:1 ratio) have been found to increase aqueous solubility of poorly water-soluble drug ornidazole. This mixed hydrotropic blend was used to prepare solid dispersion of ornidazole. DSC thermogram, XRD, and IR spectra showed that there is no interaction between drug and hydrotropic agents. Conclusion: Solid dispersions are containing a blend of urea and nicotinamide as water-soluble hydrotropic carriers show fast release of drug as compared with the pure bulk drug sample and physical mixture. The proposed techniques would be economical, convenient, and safe.
INTRODUCTION
S olid dispersion technique [1] [2] [3] [4] [5] [6] [7] [8] [9] has been utilized to increase the dissolution and thereby the rate of absorption and/or total bioavailability of poorly water-soluble drugs. The common methods of making solid dispersions are solvent evaporation, fusion, and fusion-solvent methods. Hydrotropic solid dispersion (HSD) technique [9] prohibits the use of organic solvent. Hydrotropic agents are water-soluble, whereas the drug is poor water soluble. However, in the presence of a large amount of hydrotropic agent in water, the drug gets solubilized. Then, water is removed by suitable evaporation technique to get a solid mass (a solid dispersion). Then, so formed solid dispersions shall be denoted as HSDs. Ornidazole is a 5-nitroimidazole derivative drug which has antimicrobial action. It is used in the treatment of protozoal infections, and also in the treatment and prophylaxis of anaerobic bacterial infections. [10] RESEARCH ARTICLE
MATERIALS AND METHODS

Material
Ornidazole was received as a gift sample from IPCA Laboratories Limited (Ratlam, India). Urea (Merck Ltd., Mumbai), Nicotinamide, Sodium ascorbate, Sodium gluconate, and trisodium citrate dihydrate (Qualigens Fine Chemicals, Mumbai) were used. All other chemicals and solvents were of analytical grade.
Determination of Equilibrium Solubility
Equilibrium solubilities of ornidazole in different aqueous mediums [ Table 1 ] were determined at room temperature. For determining solubility, accurately measured 3 ml of a particular blend of hydrotropic agent was taken in a 10 ml volumetric flask, and an excess amount of drug was added, and mechanically shaken until saturated solution was formed. The volumetric flask was shaken on a mechanical shaker for 12 h so that equilibrium solubility can be achieved and solution was allowed to equilibrate undisturbed for 24 h. Then, solution was centrifuged at 2000 rpm for 5 min in ultracentrifuge, and then the solution was filtered through Whatman Grade 41 filter. Aliquot was suitably diluted with purified water and analyzed using UV spectrophotometer at 319 nm. [11] Enhancement ratios insolubility [ There was a significant enhancement in solubility of drug using a blend of urea and nicotinamide in the ratio of 1:1. Therefore, optimized combination of hydrotropes was selected for the preparation of solid dispersion. Finally, ratios of drug: Carrier (a blend of urea and nicotinamide in 1:1 ratio) used for solid dispersions were 1: 2, 1:4, and 1:6.
Preparation of HSDs of Ornidazole
For preparation of 10 g HSD containing ornidazole and hydrotropic blend (10% w/w urea and 10% w/w nicotinamide) in 1:2 ratio, ornidazole (3.3331 g), urea (3.3432), and nicotinamide (3.3323) were accurately weighed. Minimum quantity of distilled water at 68°C-70°C contained in a 200 ml beaker was used to dissolve the urea and nicotinamide. Then, ornidazole was added to this beaker (at 35°C-40°C) and a Teflon-coated magnetic bead was dropped in it. Magnetic bead was stirring in a beaker using a magnetic stirrer, maintaining the temperature at 35°C-40°C until ornidazole got completely solubilized. Stirring was continued till the semisolid mass remained in beaker. Semisolid mass was spread on watch glasses in thin layers for quick drying. All the watch glasses were kept in oven, maintained the temperature at 40°C for drying. When the mass became dry, it was transferred in pestle mortar and triturated, again kept in oven for drying. After drying, the powder of solid dispersion was passed through sieve number 100 and was kept for 6 days in a desiccator containing blue silica gel. After this, the HSD powder was stored in air-tight glass bottles. Same procedure was repeated to prepare HSDs containing ornidazole and hydrotropic blend (urea: Nicotinamide -1:1) in ratios of 1:4 (using 2.0101 g ornidazole) and 1:6 (using 1.4292 g ornidazole).
PM of Ornidazole
Drug:carrier ratio 1:6 was used for preparation of PM. Ornidazole (1.4312 g), urea (4.2946 g), and nicotinamide (4.3011 g) were accurately weighed and mixed for 10 min using glass pestle and mortar with trituration. Then, powder was passed through sieve number 100. After this, the PM was stored in air-tight glass bottles.
Determination of Drug Content in Ornidazole Formulations (HSD and PM)
Solid dispersion/PM containing about 10 mg of ornidazole was accurately weighed and transferred to a 500 ml volumetric flask. About 450 ml of distilled water was added, and flask was shaken to dissolve the formulation completely. Then, volume was made up to the mark with distilled water, and the absorbance of this solution was measured at 319 nm against reagent blank. In each case, analysis was performed in triplicate. The drug content [ Table 3 ] was determined using regression equation: Y = 0.03288 X + 0.03216.
Powder X-ray Diffraction (XRD) Studies of Formulated HSD and PM
The powder XRD spectra of the prepared HSDs and the PMs were obtained using RU-H 3 R, horizontal Rotaflex rotating anode X-ray generator instrument, Rigaku, Tokyo.
Differential Scanning Calorimetry (DSC)
To obtain the DSC thermograms of the drug, solid dispersion and PM, TA Instruments-2910 modulated DSC (USA) was employed. To take DSC thermograms, 4 mg of drug or formulation of drug was weighed accurately and placed in one of the matched aluminum pan. The sample pan and the reference pan both were sealed and placed on the heating cell and covered with a glass bell jar. Heating at a rate of 10°C/min with a continuous purge of nitrogen (45 cc/min) was done with recording of energy changes in the sample with respect to the reference in the temperature range of 50°C-170°C.
Fourier-transform Infrared (FTIR) Spectroscopy
FTIR spectroscopy of drug, solid dispersion and PM were done using FTIR spectrophotometer (Shimadzu FTIR IRAffinity-1, Japan). The samples were scanned over wavenumber region of 4000-400/cm at resolution of 4/cm.
Dissolution Rate Studies of Drug and Its Formulations
Dissolution rates of bulk drug sample of ornidazole, PM (1:6), and HSD containing drug: Hydrotropic blend of 1:2, 1:4, and 1:6 ratios were studied using USP XXIV (type II) dissolution rate test apparatus. Bulk drug sample, PM, and HSDs equivalent to 100 mg drug were used to perform dissolution rate studies. Distilled water was used as dissolution medium. The stirrer was adjusted to rotate at 50 rpm. A temperature of 37 ± 0.5°C was maintained throughout the experiments. Samples (10 ml) of dissolution medium were withdrawn at known time intervals and replaced with same volume of distilled water after each withdrawal. The samples were analyzed for drug contents by measuring the absorbances of appropriately diluted sample solutions with distilled water at 319 nm wavelength. Calculations for amounts of drug released were done using regression equation Y = 0.03288 X + 0.03216.
RESULT AND DISCUSSION
The results of the solubility data [ Same peaks were observed in PM and solid dispersion of ornidazole. It shows that there is no interaction between drug and hydrotropic agents.
From the results [ Table 2 and Figure 8 ] of dissolution rate study, it is evident that the bulk drug sample exhibited poor drug release profiles. Initial rates of dissolution of drug from HSDs were very quick as compared with initial rates of dissolution from bulk drug sample. It also showed that 1:4 and 1:6 HSD were dissolved completely within 1 min. While on the other hand, pure drug and PM were not dissolved completely even after 30 min.
CONCLUSION
The solid dispersions of ornidazole were developed using the concept of mixed hydrotropic solubilization technique. Solid dispersions containing blend of urea and nicotinamide as water-soluble hydrotropic carriers show the fast release of drug as compared with the pure bulk drug sample and PM; the quick onset of action and better extent of absorption is expected after oral administration of these HSDs. The proposed techniques would be economical, convenient, and safe. Thus, the study opens the chances of preparing mixed HSD of poorly water-soluble drugs. 
